Projects
From biographical disruption to biographical construction of a hybrid identity: a qualitative study of the impact of antiretroviral treatment on the life of HIV/AIDS-patients in South Africa. University of Antwerp
Mechanisms of secondary control of HIV infection after an episode of anti-retroviral treatment. University of Antwerp
Data-driven modelling of the impact of early, wide-scale HIV treatment on HIV incidence in Southern Africa Hasselt University
High performance computing to model HIV-1 evolutionary dynamics under treatment and immune selective pressure. KU Leuven
Gene therapy for HIV/AIDS based on the interaction of HIV-integrase with LEDGF/p75. KU Leuven
Development of a novel nanoparticle formulation for mRNA based therapeutic vaccination against HIV Vrije Universiteit Brussel
not come without side-effects. Therefore, to ...
Households in HIV care: developing and testing an intervention to capitalize on the intermediate role of the household in community support for chronic HIV care. University of Antwerp
Hybrid CARs on the road to HIV cure Ghent University
Antiretroviral therapy -the current gold standard in HIV treatment- fails to provide a definitive cure. However, cell therapies for HIV are increasingly gaining ground, with the use of Chimeric Antigen Receptors (CARs) being widely explored. CAR-T cell therapies have been successfully applied in oncology, particularly in hematologic malignancies, reaching up to 90% remission. In infectious diseases, all previously explored CAR-based ...
Strategies against persistent HIV-1 reservoirs Ghent University
SAPHIR, aims to contribute to the healing of HIV-1. This project is supported by a consortium with experience in HIV diagnostics and medication development. Based on this complementary expertise of the partners becomes both the therapeutic and the diagnostic aspect of the investigation.
Currently, 37 million people worldwide are infected with HIV-1 and are affected weekly 25,000 new people worldwide are HIV-positive. Despite the ...